Klotho gene delivery ameliorates renal hypertrophy and fibrosis in streptozotocin-induced diabetic rats by suppressing the Rho-associated coiled-coil kinase signaling pathway

Deng,Minghong; Luo,Yumei; Li,Yunkui; Yang,Qiuchen; Deng,Xiaoqin; Wu,Ping; Ma,Houxun

doi:10.3892/mmr.2015.3367

Klotho gene delivery ameliorates renal hypertrophy and fibrosis in streptozotocin-induced diabetic rats by suppressing the Rho-associated coiled-coil kinase signaling pathway

Authors:
- Minghong Deng
- Yumei Luo
- Yunkui Li
- Qiuchen Yang
- Xiaoqin Deng
- Ping Wu
- Houxun Ma
View Affiliations

Affiliations: Department of Geriatrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China
Published online on: February 17, 2015 https://doi.org/10.3892/mmr.2015.3367
Pages: 45-54
Copyright: © Deng et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to investigate whether klotho gene delivery attenuated renal hypertrophy and fibrosis in streptozotocin‑induced diabetic rats. A recombinant adeno‑associated virus (rAAV) carrying mouse klotho full‑length cDNA (rAAV.mKL), was constructed for in vivo investigation of klotho expression. Diabetes was induced in rats by a single tail vein injection of 60 mg/kg streptozotocin. Subsequently, the diabetic rats received an intravenous injection of rAAV.mKL, rAAV.green fluorescent protein (GFP) or phosphate‑buffered saline (PBS). The Sprague‑Dawley rat group received PBS and served as the control group. After 12 weeks, all the rats were sacrificed and ELISA, immunohistochemical and histological analyses, fluorescence microscopy, semi‑quantitative reverse transcription‑polymerase chain reaction and western blottin were performed. A single dose of rAAV.mKL was found to prevent the progression of renal hypertrophy and fibrosis for at least 12 weeks (duration of study). Klotho expression was suppressed in the diabetic rats, but was increased by rAAV.mKL delivery. rAAV.mKL significantly suppressed diabetes‑induced renal hypertrophy and histopathological changes, reduced renal collagen fiber generation and decreased kidney hypertrophy index. In addition, rAAV.mKL decreased the protein expression levels of fibronectin and vimentin, while it downregulated the mRNA expression and activity of Rho‑associated coiled‑coil kinase (ROCK)I in the kidneys of the diabetic rats. These results indicated that klotho gene delivery ameliorated renal hypertrophy and fibrosis in diabetic rats, possibly by suppressing the ROCK signaling pathway. This may offer a novel approach for the long‑term control and renoprotection of diabetes.

View Figures

View References

1	Kuro-o M, Matsumura Y, Aizawa H, et al: Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 390:45–51. 1997. View Article : Google Scholar : PubMed/NCBI
2	Masuda H, Chikuda H, Suga T, Kawaguchi H and Kuro-o M: Regulation of multiple ageing-like phenotypes by inducible klotho gene expression in klotho mutant mice. Mech Ageing Dev. 126:1274–1283. 2005. View Article : Google Scholar : PubMed/NCBI
3	Kurosu H, Yamamoto M, Clark JD, et al: Suppression of aging in mice by the hormone Klotho. Science. 309:1829–1833. 2005. View Article : Google Scholar : PubMed/NCBI
4	Ishizaka N, Matsuzaki G, Saito K, Furuta K, Mori I and Nagai R: Downregulation of klotho gene expression in streptozotocin-induced diabetic rats. Geriatr Gerontol Int. 7:285–292. 2007. View Article : Google Scholar
5	Cheng MF, Chen LJ and Cheng JT: Decrease of Klotho in the kidney of streptozotocin-induced diabetic rats. J Biomed Biotechnol. 2010:5138532012.
6	Nagasu H, Satoh M, Kuwabara A, et al: Overexpression of klotho protein modulates uninephrectomy-induced compensatory renal hypertrophy by suppressing IGF-I signals. Biochem Biophys Res Commun. 407:39–43. 2011. View Article : Google Scholar : PubMed/NCBI
7	Haruna Y, Kashihara N, Satoh M, et al: Amelioration of progressive renal injury by genetic manipulation of Klotho gene. Proc Natl Acad Sci USA. 104:2331–2336. 2007. View Article : Google Scholar : PubMed/NCBI
8	Sugiura H, Yoshida T, Shiohira S, et al: Reduced klotho expression level in kidney aggravates renal interstitial fibrosis. Am J Physiol Renal Physiol. 302:1252–1264. 2012. View Article : Google Scholar
9	Doi S, Zou Y, Togao O, et al: Klotho inhibits transforming growth factor-β1 (TGF-β1) signaling and suppresses renal fibrosis and cancer metastasis in mice. J Biol Chem. 286:8655–8665. 2011. View Article : Google Scholar : PubMed/NCBI
10	Satoh M, Nagasu H, Morita Y, Yamaguchi TP, Kanwar YS and Kashihara N: Klotho protects against mouse renal fibrosis by inhibiting Wnt signaling. Am J Physiol Renal Physiol. 303:F1641–F1651. 2012. View Article : Google Scholar : PubMed/NCBI
11	Shimokawa H and Takeshita A: Rho-kinase is an important therapeutic target in cardiovascular medicine. Arterioscler Thromb Vasc Biol. 25:1767–1775. 2005. View Article : Google Scholar : PubMed/NCBI
12	Uehata M, Ishizaki T, Satoh H, et al: Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature. 389:990–994. 1997. View Article : Google Scholar : PubMed/NCBI
13	Kikuchi Y, Yamada M, Imakiire T, et al: A Rho-kinase inhibitor, fasudil, prevents development of diabetes and nephropathy in insulin-resistant diabetic rats. J Endocrinol. 192:595–603. 2007. View Article : Google Scholar : PubMed/NCBI
14	Kawamura H, Yokote K, Asaumi S, et al: High glucose-induced upregulation of osteopontin is mediated via Rho/Rho kinase pathway in cultured rat aortic smooth muscle cells. Arterioscler Thromb Vasc Biol. 24:276–281. 2004. View Article : Google Scholar
15	Reiniger N, Lau K, McCalla D, et al: Deletion of the receptor for advanced glycation end products reduces glomerulosclerosis and preserves renal function in the diabetic OVE26 mouse. Diabetes. 59:2043–2054. 2010. View Article : Google Scholar : PubMed/NCBI
16	Zhang Y, Peng F, Gao B, et al: Mechanical strain-induced RhoA activation requires NADPH oxidase-mediated ROS generation in caveolae. Antioxid Redox Signal. 13:959–973. 2010. View Article : Google Scholar : PubMed/NCBI
17	Seibold S, Schürle D, Heinloth A, et al: Oxidized LDL induces proliferation and hypertrophy in human umbilical vein endothelial cells via regulation of p27Kip1 expression: role of RhoA. J Am Soc Nephrol. 15:3026–3034. 2004. View Article : Google Scholar : PubMed/NCBI
18	Komers R: Rho kinase inhibition in diabetic nephropathy. Curr Opin Nephrol Hypertens. 20:77–83. 2011. View Article : Google Scholar
19	Kolavennu V, Zeng L, Peng H, Wang Y and Danesh FR: Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control. Diabetes. 57:714–723. 2008. View Article : Google Scholar
20	Peng F, Wu D, Gao B, Ingram AJ, Zhang B, Chorneyko K, McKenzie R and Krepinsky JC: RhoA/Rho-kinase contribute to the pathogenesis of diabetic renal disease. Diabetes. 57:1683–1692. 2008. View Article : Google Scholar : PubMed/NCBI
21	Komers R, Oyama TT, Beard DR, Tikellis C, Xu B, Lotspeich DF and Anderson S: Rho kinase inhibition protects kidneys from diabetic nephropathy without reducing blood pressure. Kidney Int. 79:432–442. 2011. View Article : Google Scholar
22	Patel S, Takagi KI, Suzuki J, Imaizumi A, Kimura T, Mason RM, Kamimura T and Zhang Z: RhoGTPase activation is a key step in renal epithelial mesenchymal transdifferentiation. J Am Soc Nephrol. 16:1977–1984. 2005. View Article : Google Scholar : PubMed/NCBI
23	Rodrigues-Díez R, Carvajal-González G, Sánchez-López E, Rodríguez-Vita J, Rodrigues Díez R, Selgas R, Ortiz A, Egido J, Mezzano S and Ruiz-Ortega M: Pharmacological modulation of epithelial mesenchymal transition caused by angiotensin II. Role of ROCK and MAPK pathways. Pharm Res. 25:2447–2461. 2008. View Article : Google Scholar : PubMed/NCBI
24	Lin G, Craig GP, Zhang L, Yuen VG, Allard M, McNeill JH and MacLeod KM: Acute inhibition of Rho-kinase improves cardiac contractile function in streptozotocin-diabetic rats. Cardiovasc Res. 75:51–58. 2007. View Article : Google Scholar : PubMed/NCBI
25	Sharma V, Parsons H, Allard MF and McNeill JH: Metoprolol increases the expression of β3-adrenoceptors in the diabetic heart: effects on nitric oxide signaling and forkhead transcription factor-3. Eur J Pharmacol. 595:44–51. 2008. View Article : Google Scholar : PubMed/NCBI
26	Ziyadeh EF: The extracellular matrix in diabetic nephropathy. Am J Kidney Dis. 22:736–744. 1993. View Article : Google Scholar : PubMed/NCBI
27	Wolf G and Ziyadeh FN: Molecular mechanisms of diabetic renal hypertrophy. Kidney Int. 56:393–405. 1999. View Article : Google Scholar : PubMed/NCBI
28	Chen JK, Chen J, Neilson EG and Harris RC: Role of mammalian target of rapamycin signaling in compensatory renal hypertrophy. J Am Soc Nephrol. 16:1384–1391. 2005. View Article : Google Scholar : PubMed/NCBI
29	Chen JK, Chen J, Thomas G, Kozma SC and Harris RC: S6 kinase 1 knockout inhibits uninephrectomy- or diabetes-induced renal hypertrophy. Am J Physiol Renal Physiol. 297:585–593. 2009. View Article : Google Scholar
30	Ozeki M, Nagasu H, Satoh M, Namikoshi T, Haruna Y, Tomita N, Sasaki T and Kashihara N: Reactive oxygen species mediate compensatory glomerular hypertrophy in rat uninephrectomized kidney. J Physiol Sci. 59:397–373. 2009. View Article : Google Scholar : PubMed/NCBI
31	Mauer SM, Lane P, Zhu D, Fioretto P and Steffes MW: Renal structure and function in insulin-dependent diabetes mellitus in man. J Hypertens Suppl. 10:S17–S20. 1992. View Article : Google Scholar : PubMed/NCBI
32	Van Vliet A, Baelde HJ, Vleming LJ, de Heer E and Bruijn JA: Distribution of fibronectin isoforms in human renal disease. J Pathol. 193:256–262. 2001. View Article : Google Scholar : PubMed/NCBI
33	Carew RW, Wang B and Kantharidis P: The role of EMT in renal fibrosis. Cell Tissue Res. 347:103–116. 2012. View Article : Google Scholar
34	Kalluri R and Neilson EG: Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest. 112:1776–1784. 2003. View Article : Google Scholar : PubMed/NCBI
35	Moeller MJ, Soofi A, Hartmann I, Le Hir M, Wiggins R, Kriz W and Holzman LB: Podocytes populate cellular crescents in a murine model of inflammatory glomerulonephritis. J Am Soc Nephrol. 15:61–67. 2004. View Article : Google Scholar
36	Zeisberg EM, Potenta SE, Sugimoto H, Zeisberg M and Kalluri R: Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol. 19:2282–2287. 2008. View Article : Google Scholar : PubMed/NCBI
37	Galichon P and Hertig A: Epithelial to mesenchymal transition as a biomarker in renal fibrosis: are we ready for the bedside? Fibrogenesis Tissue Repair. 4:112011. View Article : Google Scholar : PubMed/NCBI
38	Guan SJ, Ma ZH, Wu YL, Zhang JP, Liang F, Weiss JW, Guo QY, Wang JY, Ji ES and Chu L: Long-term administration of fasudil improves cardiomyopathy in streptozotocin-induced diabetic rats. Food Chem Toxicol. 50:1874–1882. 2012. View Article : Google Scholar : PubMed/NCBI
39	Narumiya H, Sasaki S, Kuwahara N, et al: HMG-CoA reductase inhibitors up-regulate anti-aging klotho mRNA via RhoA inactivation in IMCD3 cells. Cardiovasc Res. 64:331–336. 2004. View Article : Google Scholar : PubMed/NCBI
40	Oi K, Shimokawa H, Hiroki J, et al: Remnant lipoproteins from patients with sudden cardiac death enhance coronary vasospastic activity through upregulation of Rho-kinase. Arterioscler Thromb Vasc Biol. 24:918–922. 2004. View Article : Google Scholar : PubMed/NCBI
41	Hiroki J, Shimokawa H, Higashi M, et al: Inflammatory stimuli upregulate Rho-kinase in human coronary vascular smooth muscle cells. J Mol Cell Cardiol. 37:537–546. 2004. View Article : Google Scholar : PubMed/NCBI
42	Zhao Y, Banerjee S, Dey N, et al: Klotho depletion contributes to increased inflammation in kidney of the db/db mouse model of diabetes via RelA (serine) 536 phosphorylation. Diabetes. 60:1907–1916. 2011. View Article : Google Scholar : PubMed/NCBI
43	Urakawa I, Yamazaki Y, Shimada T, et al: Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature. 444:770–774. 2006. View Article : Google Scholar : PubMed/NCBI
44	Wang Y and Sun Z: Current understanding of klotho. Ageing Res Rev. 8:43–51. 2009. View Article : Google Scholar :
45	Hu MC, Kuro-o M and Moe OW: Renal and extrarenal actions of Klotho. Semin Nephrol. 33:118–129. 2013. View Article : Google Scholar : PubMed/NCBI
46	Koh N, Fujimori T, Nishiguchi S, Tamori A and Shiomi S: Severely reduced production of klotho in human chronic renal failure kidney. Biochem Biophys Res Commun. 280:1015–1020. 2001. View Article : Google Scholar : PubMed/NCBI
47	Weroha SJ and Haluska P: IGF-1 Receptor Inhibitors in Clinical Trials-Early Lessons. J Mammary Gland Biol Neoplasia. 13:471–483. 2008. View Article : Google Scholar : PubMed/NCBI
48	Huang SM, Mishina YM, Liu S, et al: Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature. 461:614–620. 2009. View Article : Google Scholar : PubMed/NCBI
49	Yingling JM, Blanchard KL and Sawyer JS: Development of TGF-β signalling inhibitors for cancer therapy. Nat Rev Drug Discov. 3:1011–1022. 2004. View Article : Google Scholar : PubMed/NCBI
50	Prud’homme GJ: Pathobiology of transforming growth factor β in cancer, fibrosis and immunologic disease, and therapeutic considerations. Lab Invest. 7:1077–1091. 2007. View Article : Google Scholar